Pilyugin M - Search Results

1

Histone chaperones ASF1 and NAP1 differentially modulate removal of active histone marks by LID-RPD3 complexes during NOTCH silencing.

Moshkin YM, Kan TW, Goodfellow H, Bezstarosti K, Maeda RK, Pilyugin M, Karch F, Bray SJ, Demmers JA, Verrijzer CP. Moshkin YM, et al. Among authors: pilyugin m. Mol Cell. 2009 Sep 24;35(6):782-93. doi: 10.1016/j.molcel.2009.07.020. Mol Cell. 2009. PMID: 19782028 Free article.

2

Phosphorylation-mediated control of histone chaperone ASF1 levels by Tousled-like kinases.

Pilyugin M, Demmers J, Verrijzer CP, Karch F, Moshkin YM. Pilyugin M, et al. PLoS One. 2009 Dec 16;4(12):e8328. doi: 10.1371/journal.pone.0008328. PLoS One. 2009. PMID: 20016786 Free PMC article.

3

HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or b.

Lepore I, Dell'Aversana C, Pilyugin M, Conte M, Nebbioso A, De Bellis F, Tambaro FP, Izzo T, Garcia-Manero G, Ferrara F, Irminger-Finger I, Altucci L. Lepore I, et al. Among authors: pilyugin m. PLoS One. 2013 Dec 11;8(12):e83018. doi: 10.1371/journal.pone.0083018. eCollection 2013. PLoS One. 2013. PMID: 24349422 Free PMC article.

4

Assembly of Polycomb complexes and silencing mechanisms.

Pirrotta V, Poux S, Melfi R, Pilyugin M. Pirrotta V, et al. Among authors: pilyugin m. Genetica. 2003 Mar;117(2-3):191-7. doi: 10.1023/a:1022992011833. Genetica. 2003. PMID: 12723698 Review.

5

New concepts on BARD1: Regulator of BRCA pathways and beyond.

Irminger-Finger I, Ratajska M, Pilyugin M. Irminger-Finger I, et al. Among authors: pilyugin m. Int J Biochem Cell Biol. 2016 Mar;72:1-17. doi: 10.1016/j.biocel.2015.12.008. Epub 2015 Dec 29. Int J Biochem Cell Biol. 2016. PMID: 26738429 Free article. Review.

6

BARD1 serum autoantibodies for the detection of lung cancer.

Pilyugin M, Descloux P, André PA, Laszlo V, Dome B, Hegedus B, Sardy S, Janes S, Bianco A, Laurent GJ, Irminger-Finger I. Pilyugin M, et al. PLoS One. 2017 Aug 7;12(8):e0182356. doi: 10.1371/journal.pone.0182356. eCollection 2017. PLoS One. 2017. PMID: 28786985 Free PMC article.

7

Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs.

Pilyugin M, Irminger-Finger I. Pilyugin M, et al. Int J Biochem Cell Biol. 2014 Sep;54:356-67. doi: 10.1016/j.biocel.2014.06.018. Epub 2014 Jul 5. Int J Biochem Cell Biol. 2014. PMID: 25008968

8

Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome.

Zhang YQ, Pilyugin M, Kuester D, Leoni VP, Li L, Casula G, Zorcolo L, Schneider-Stock R, Atzori L, Irminger-Finger I. Zhang YQ, et al. Among authors: pilyugin m. Br J Cancer. 2012 Aug 7;107(4):675-83. doi: 10.1038/bjc.2012.297. Epub 2012 Jul 19. Br J Cancer. 2012. PMID: 22814582 Free PMC article.

9

BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer.

Pilyugin M, Ratajska M, Stukan M, Concin N, Zeillinger R, Irminger-Finger I. Pilyugin M, et al. Genes (Basel). 2021 Jun 25;12(7):969. doi: 10.3390/genes12070969. Genes (Basel). 2021. PMID: 34201956 Free PMC article.

10

Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms.

Ratajska M, Matusiak M, Kuzniacka A, Wasag B, Brozek I, Biernat W, Koczkowska M, Debniak J, Sniadecki M, Kozlowski P, Klonowska K, Pilyugin M, Wydra D, Laurent G, Limon J, Irminger-Finger I. Ratajska M, et al. Among authors: pilyugin m. Oncol Rep. 2015 Nov;34(5):2609-17. doi: 10.3892/or.2015.4235. Epub 2015 Sep 1. Oncol Rep. 2015. PMID: 26329992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page